top of page
ConDUC.png
ConDUC.png
ConDUC.png
Doctor's Desk
CONDUC WHITE.png

The Consortium Of Disparities Of Urologic Conditions

Who We Are?

ConDUC was established in 2017 to develop strategies to improve disparate outcomes in high-risk populations with urological diseases.  This nonprofit initiative is specifically targeted toward eliminating health disparities in prostate cancer and improving outcomes to at risk populations through data-driven, community centered research.

 

Our dedicated team comprised  of  urologists, radiation oncologists, translational and clinical researchers, healthcare advocates,  and pharmaceutical leaders carry out this work through active programming and initiatives targeting the following objectives:

  • Enrollment and Active Participation in Clinical Studies

  • Student Mentorship and Training

  • PSA Screening and Early Detection

  • Strategic Partnerships and Community Engagement

Our Core Values

Scientific Integrity

Inclusiveness

Stewardship

Transparency

Cultural Sensitivity

Meet Our Board

Our dedicated team comprised  of  urologists, radiation oncologists, translational and clinical researchers, healthcare advocates,  and pharmaceutical leaders

5a88e6b03f46d7070520468f0d9fefbe.jpeg

Walter Rayford, M.D., PhD, MBA Executive Director

Director The Urology Group

Robert Waterhouse, M.D., MBA

Chief Medical Officer/VP Value Based Care Baylor Scott and White Health

Curtis Pettaway, M.D.

Chief Scientific Officer & Professor MD Anderson Cancer Center

Jean Jospeh, M.D., MBA

Professor & Chair Department of Urology University of Rochester

Vincent M. Bivins, M.D., FACS

President Urology Centers of Alabama

Brian Stone, M.D., FACS

President Jasper Urology

Arthur Burnett, M.D., MBA, FACS

Professor Department of Urology | Oncology John Hopkins University School of Medicine | Partner Of Urology Group

John McGill, M.D., MBA, Director of Community Engagement

Urologist | Phoebe Physician Group

Kelvin Moses, M.D., PhD

Associate Professor Department of Urology Fellowship Director | Urologic Oncology Fellowship Vanderbilt University Medical Center

Randy Bradley, PhD, CPHIMS, FHIMSS

Associate Professor Haslam College of Business University of Tennessee, Knoxville EVP, Digital Transformations in Life Sciences Bio Supply Management Alliance (BSMA)

Olorunseun O. Ogunwobi, M.D., PhD

Chair, External Advisory Board Director | Hunter College Center for Cancer Health Disparities Research (CCHDR) | Associate Professor of Biological Sciences, Hunter College The City University of New York

Kelly Brown-Morris

Chief Development Officer (CDO) | Center For Cancer Research & Therapeutic Development, Clark Atlanta University

Our Valued Sponsors & Partners

Inquire about becoming a sponsor or donor.

Amgen
Bristol Myers Squibb
Janssen
Veracyte
AstraZeneca
Clark Atlanta University
Boston Scientific
Myriad Genetics
City Of Hope
American Cancer Society
bottom of page